Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective study

Trabectedin is a therapeutic option for patients with advanced sarcoma. While a randomized trial demonstrated its prolonged progression-free survival (PFS), the reported PFS was <6 months. Some patients can achieve long-term disease control with this treatment. However, the reference information...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmoto, Akihiro, Nakano, Kenji, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Hayashi, Naomi, Suto, Hirotaka, Udagawa, Shohei, Oki, Ryosuke, Sato, Yasuyoshi, Yunokawa, Mayu, Ono, Makiko, Saito, Masanori, Minami, Yusuke, Hayakawa, Keiko, Tanizawa, Taisuke, Ae, Keisuke, Matsumoto, Seiichi, Tomomatsu, Junichi, Takahashi, Shunji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977011/
https://www.ncbi.nlm.nih.gov/pubmed/36857355
http://dx.doi.org/10.1371/journal.pone.0280508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977011/
https://www.ncbi.nlm.nih.gov/pubmed/36857355
http://dx.doi.org/10.1371/journal.pone.0280508

Ejemplares similares